CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a novel immunotherapy for glioblastoma, a highly aggressive brain tumor. By combining engineered alphaviruses with immunotherapy techniques, it aims to enhance the therapeutic response and improve survival rates for patients suffering from this fatal condition.
Alphaviral Immunotherapy against GlioblastomaGlioblastomas (GBM) are the most frequent type of primary brain tumours with no treatment or cure available.
Despite the current standard care, GBMs remain 100% fatal with median survival of patients for only 12 - 15 months.
Thus, there is an urgent need for novel effective therapies.Among the emerging new therapeutic approaches is oncolytic virotherapy with replicative viruses that kill cancer cells.
During his PhD studies, the applicant researcher,…
UPPSALA UNIVERSITET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
